ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,918Medicare Part D Prescriptions Filled, Including Refills

Rank: 119 out of 2456

$637K Total Retail Price of All Prescriptions

Rank: 137 out of 2456

651 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 651 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 651 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 10,635 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 734 663 1 1
ATENOLOL 606 561 2 6
HYDROCHLOROTHIAZIDE 565 519 3 7
SIMVASTATIN 522 407 4 2
LEVOTHYROXINE SODIUM 414 391 5 4
METOPROLOL TARTRATE 365 340 6 10
ATORVASTATIN CALCIUM 336 297 7 12
FUROSEMIDE 331 314 8 8
WARFARIN SODIUM 281 271 9 9
LORAZEPAM 246 233 10 67
GABAPENTIN 226 193 11 16
OMEPRAZOLE 214 177 12 3
METFORMIN HCL 213 161 13 11
AMLODIPINE BESYLATE 212 210 14 5
METOPROLOL SUCCINATE 175 166 15 13
RANITIDINE HCL 171 160 16 31
SERTRALINE HCL 152 146 17 21
ALLOPURINOL 144 141 18 27
KLOR-CON M20 139 130 19 69
DEXILANT 135 111 20 114
CITALOPRAM HBR 132 115 21 14
INSULIN SYRINGE 126 95 22 72
HYDROCODONE-ACETAMINOPHEN 123 104 S3 23 20
GLYBURIDE 119 99 R 24 40
TRAMADOL HCL 96 65 25 24
OXYCODONE-ACETAMINOPHEN 92 74 S2 26 35
LOVASTATIN 90 87 27 34
DIOVAN 88 84 28 26
PROAIR HFA 86 71 29 22
LOSARTAN POTASSIUM 85 85 30 18
LANTUS 83 72 31 44
CHLORTHALIDONE 83 67 31 96
HUMULIN N 80 69 33 187
FLUTICASONE PROPIONATE 77 72 34 30
CLOPIDOGREL 74 59 35 55
DIGOXIN 74 74 35 49
DILTIAZEM 24HR ER 68 58 37 78
HUMALOG 68 63 37 123
TAMSULOSIN HCL 66 58 39 32
FLUOXETINE HCL 65 59 40 45
CIPROFLOXACIN HCL 63 56 41 87
PREDNISONE 63 52 41 39
HUMALOG MIX 75-25 62 57 43 258
AZITHROMYCIN 62 50 43 60
CEFPODOXIME PROXETIL 62 58 43 240
TRAZODONE HCL 60 47 46 17
TERAZOSIN HCL 58 58 47 76
ZOSTAVAX 58 56 47 122
FINASTERIDE 58 58 47 66
GLIPIZIDE 54 54 50 46
MECLIZINE HCL 53 42 51 107
LIDODERM 52 49 52 58
LIPITOR 50 38 53 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 25, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.